IMPACT OF RIFAXIMIN ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME

被引：0
|
作者：
Cash, Brooks D.
Heimanson, Zeev
Chang, Lin
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1599
引用
收藏
页码：S913 / S913
页数：1
相关论文
共 50 条
  • [1] IMPACT OF RIFAXIMIN ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME
    Cash, Brooks D.
    Heimanson, Zeev
    Chang, Lin
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2017, 32 : S218 - S219
  • [2] Rifaximin in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome
    Dai, Cong
    Jiang, Min
    Sun, Ming-Jun
    GASTROENTEROLOGY, 2017, 152 (06) : 1629 - +
  • [3] Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome
    Kane, John S.
    Ford, Alexander C.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (04) : 431 - 442
  • [4] Rifaximin in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome Reply
    Lembo, Anthony J.
    GASTROENTEROLOGY, 2017, 152 (06) : 1630 - +
  • [5] Rifaximin significantly improves quality of life versus placebo in patients with diarrhea-predominant irritable bowel syndrome
    Chey, William
    Talley, N.
    Lembo, A.
    Yu, J.
    Bortey, E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S461 - S462
  • [6] RIFAXIMIN IS A SAFE THERAPY FOR DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME
    Weinstock, Leonard B.
    Pimentel, Mark
    Heimanson, Zeev
    Lembo, Anthony
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S331 - S332
  • [7] Impact of Bile Acid Diarrhea in Patients With Diarrhea-Predominant Irritable Bowel Syndrome on Symptoms and Quality of Life
    BouSaba, Joelle
    Sannaa, Wassel
    McKinzie, Sanna
    Vijayvargiya, Priya
    Chedid, Victor
    Wang, Xiao Jing
    Atieh, Jessica
    Zheng, Ting
    Brandler, Justin
    Taylor, Ann L.
    Busciglio, Irene
    Harmsen, W. Scott
    Camilleri, Michael
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (09) : 2083 - +
  • [8] Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome
    Lembo, Anthony
    Pimentel, Mark
    Rao, Satish S.
    Schoenfeld, Philip
    Cash, Brooks
    Weinstock, Leonard B.
    Paterson, Craig
    Bortey, Enoch
    Forbes, William P.
    GASTROENTEROLOGY, 2016, 151 (06) : 1113 - 1121
  • [9] Pharmacokinetic drug evaluation of rifaximin for treatment of diarrhea-predominant irritable bowel syndrome
    Bruzzese, Eugenia
    Pesce, Marcella
    Sarnelli, Giovanni
    Guarino, Alfredo
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (07) : 753 - 760
  • [10] The efficacy of cognitive-behavior group therapy on health-related quality of life, health anxiety and depression in patients with diarrhea-predominant irritable bowel syndrome
    Haghayegh, Sayed Abbas
    Kalantari, Mehrdad
    Molavi, Hosein
    Talebi, Majid
    Alemohamad, Javad
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2011, 27 (04) : 749 - 753
12345